| Literature DB >> 29664368 |
Hauke Janssen, Iryna Janssen, Paul Cooper, Clemens Kainyah, Theresia Pellio, Michael Quintel, Mathieu Monnheimer, Uwe Groß, Marco H Schulze.
Abstract
Wound infections are an emerging medical problem worldwide, frequently neglected in under-resourced countries. Bacterial culture and antimicrobial drug resistance testing of infected wounds in patients in a rural hospital in Ghana identified no methicillin-resistant Staphylococcus aureus or carbapenem-resistant Enterobacteriaceae but identified high combined resistance of Enterobacteriaceae against third-generation cephalosporins and fluoroquinolones.Entities:
Keywords: AMR; Enterobacteriaceae; Ghana; MRSA; antimicrobial resistance; bacteria; gram-negative bacteria; multiresistant; polymicrobial infections; resistance; rural; wound infections
Mesh:
Substances:
Year: 2018 PMID: 29664368 PMCID: PMC5938797 DOI: 10.3201/eid2405.171506
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Percentages of antimicrobial drug resistance in selected bacterial species in wound infections, Ghana, 2014*
| Drug | % Resistant | |||||||
|---|---|---|---|---|---|---|---|---|
| PEN | 93.5 | |||||||
| AMP | 0 | 70.0 | 94.7 | 100 | 100 | |||
| OXA | 0 | |||||||
| SAM | 0 | 45.0 | 82.2 | 69.2 | 100 | |||
| TZP | 0 | 10.5 | 46.2 | 30.0 | 10.0 | |||
| CXM | 5.0 | 57.9 | 46.2 | 80.0 | ||||
| CTX | 5.0 | 47.4 | 46.2 | 40.0 | ||||
| CAZ | 5.0 | 47.4 | 46.2 | 40.0 | 5.0 | 37.5† | ||
| IPM | 0 | 0 | ||||||
| MEM | 0 | 0 | 0 | 0 | 5.0 | 0 | ||
| ERY | 3.2 | 100 | ||||||
| CLI | 3.2 | 100 | ||||||
| TET | 67.7 | 100 | ||||||
| GEN | 3.2 | 15.0 | 46.2 | 46.2 | 40.0 | 10.0 | 62.5 | |
| AMI | 0 | 0 | ||||||
| CIP | 20.0 | 46.2 | 46.2 | 30.0 | 15.0 | 37.5 | ||
| LVX | 0 | |||||||
| SXT | 32.3 | 100 | 75.0 | 69.2 | 69.2 | 50.0 | ||
| FOF | 0 | |||||||
| RIF | 0 | |||||||
| VAN | 0 | 0 | ||||||
*Antimicrobial susceptibility testing was performed with VITEK 2 (bioMérieux, Marcy-l'Étoile, France) according to the EUCAST breakpoint tables for interpretation of MICs, version 4.0, 2014 (). Blank cells indicate no testing performed. AMI, amikacin; AMP, ampicillin; CAZ, ceftazidime; CIP, ciprofloxacin; CLI, clindamycin; CTX, cefotaxime; CXM, cefuroxime; ERY, erythromycin; FOF, fosfomycin; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM, meropenem; OXA, oxacillin; PEN, penicillin; RIF, rifampin; SAM, ampicillin/sulbactam; SXT, trimethoprim/sulfamethoxazole; TET, tetracycline; TZP, piperacillin/tazobactam; VAN, vancomycin. †The interpretation of the CAZ MIC for A. baumannii complex followed the recommendations of the Clinical and Laboratory Standards Institute performance standards for antimicrobial susceptibility testing ().
Ratio of percentages of antimicrobial drug resistance against third-generation cephalosporin CTX and the fluoroquinolone CIP in selected Enterobacteriaceae isolated from wound infections, Ghana, 2014*
| Drug resistance | % Resistant | |||
|---|---|---|---|---|
| CTX-S + CIP-S | 80.0 | 42.1 | 53.8 | 60.0 |
| CTX-S + CIP-R | 15.0 | 10.5 | ND | ND |
| CTX-R + CIP-S | ND | 5.3 | ND | 10.0 |
| CTX-R + CIP-R | 5.0 | 42.1 | 46.2 | 30.0 |
*Antimicrobial susceptibility testing was performed by using VITEK 2 (bioMérieux, Marcy-l'Étoile, France) according to the EUCAST breakpoint tables for interpretation of MICs, version 4.0, 2014 (). CIP, ciprofloxacin; CTX, cefotaxime; ND, not detected; R, resistant; S, susceptible.